Protagenic Therapeutics, Inc. (NASDAQ:PTIX – Get Free Report)’s stock price fell 6.5% during mid-day trading on Monday . The company traded as low as $0.25 and last traded at $0.26. 86,433 shares were traded during mid-day trading, a decline of 86% from the average session volume of 637,944 shares. The stock had previously closed at $0.28.
Protagenic Therapeutics Stock Down 2.1 %
The company has a market capitalization of $1.90 million, a P/E ratio of -0.21 and a beta of 0.43. The firm has a fifty day simple moving average of $0.32 and a 200-day simple moving average of $0.50.
About Protagenic Therapeutics
Protagenic Therapeutics, Inc, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses.
Recommended Stories
- Five stocks we like better than Protagenic Therapeutics
- What is Put Option Volume?
- Energy Transfer: Powering Data With Dividends and Diversification
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Qualcomm Stock Is Coiling for a Breakout
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Protagenic Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Protagenic Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
